Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000325284 | SCV000346417 | uncertain significance | Marshall syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000389263 | SCV000346418 | uncertain significance | Stickler Syndrome, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000294996 | SCV000346419 | uncertain significance | Fibrochondrogenesis 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000600627 | SCV000728702 | benign | not specified | 2017-11-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001515354 | SCV001723408 | benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000600627 | SCV001808403 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000600627 | SCV001919599 | benign | not specified | no assertion criteria provided | clinical testing |